Cov1 Spike Protein
Human-COVID-19-Spike-Protein-IgG-ELISA-Kit |
|||
E28AB0167 | EnoGene | N/A | EUR 666.67 |
Description: N/A |
Human IgG antibody Laboratories manufactures the cov1 spike protein reagents distributed by Genprice. The Cov1 Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Cov1 products are available in stock. Specificity: Cov1 Category: Spike Group: Protein
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Human,-Human-IgG1.Affinity:(mol)4.15*10-10(Fortebio),-1.07-nM(ELISA).-FACs-Blocking:-0.892-nM- | EUR 416.5 |
Description: Human, Human IgG1.Affinity: (mol) 4.15*10-10 (Fortebio), 1.07 nM (ELISA) . FACs Blocking: 0.892 nM |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Human,-Human-IgG1.Affinity:(mol)6.99*10-10(Fortebio),0.38-nM(ELISA).-FACs-Blocking:-0.803-nM- | EUR 416.5 |
Description: Human, Human IgG1.Affinity: (mol) 6.99*10-10 (Fortebio) , 0.38 nM (ELISA) . FACs Blocking: 0.803 nM |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Human,-Human-IgG1.-Affinity:(mol)3.1*10-10(Fortebio)0.3-nM(ELISA).-FACs-Blocking:-0.889-nM. | EUR 416.5 |
Description: Human, Human IgG1. Affinity: (mol) 3.1*10-10 (Fortebio) 0.3 nM (ELISA) . FACs Blocking: 0.889 nM. |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Humanized-Monoclonal-Antibody,-human-IgG1.-Affinity:0.561-nM(By-ELISA) | EUR 416.5 |
Description: Humanized Monoclonal Antibody, human IgG1. Affinity:0.561 nM (By ELISA) |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Humanized-Monoclonal-Antibody.-human-IgG1.-Affinity:0.762-nM(By-ELISA) | EUR 416.5 |
Description: Humanized Monoclonal Antibody. human IgG1. Affinity:0.762 nM (By ELISA) |
JBS True Blue |
||
Jena Bioscience GmbH | 300µl | EUR 13.7 |
JBS True Blue |
||
MiTeGen | 300 µl | EUR 16 |
Description: JBS True Blue |
COVID-19 Spike Protein Receptor Binding Domain a.a. 300-600 |
|||
00224-V-100ugvial | Virogen | 100 ug/vial | EUR 150 |
Description: COVID-19 Spike Protein Receptor Binding Domain a.a. 300-600 |
2019 nCoV/COVID19 Spike protein S1 Recombinant-His tag (100 µg) |
|||
BSV-COV-PR-36 | BioServUK | 100 ug | EUR 442 |
Description: 2020 nCoV/COVID19 Spike protein S1 Recombinant-His tag (100 µg) |
2019 nCoV/COVID19 Spike protein S1 Recombinant-His tag (500 µg) |
|||
BSV-COV-PR-37 | BioServUK | 500 ug | EUR 1580 |
Description: 2020 nCoV/COVID19 Spike protein S1 Recombinant-His tag (500 µg) |
2019 nCoV/COVID19 Spike protein S Recombinant (S1+S2), His-tag |
|||
BSV-COV-PR-40 | BioServUK | 100 ug | EUR 442 |
Description: 2019 nCoV/COVID19 Spike protein S Recombinant (S1+S2), His-tag |
2019 nCoV/COVID19 Spike protein S Recombinant (S1+S2), His-tag |
|||
BSV-COV-PR-41 | BioServUK | 500 ug | EUR 1264 |
Description: 2019 nCoV/COVID19 Spike protein S Recombinant (S1+S2), His-tag |
SARS-CoV-2(COVID-19) Spike Recombinant Protein |
|||
10-411 | ProSci | 0.1 mg | EUR 714.3 |
Description: Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike Recombinant Protein |
|||
20-233 | ProSci | 0.1 mg | EUR 726.9 |
Description: SARS-CoV-2 (COVID-19) Spike Recombinant Protein |
SARS-CoV-2 (COVID-19) Spike Recombinant Protein |
|||
11-073 | ProSci | 0.1 mg | EUR 695.4 |
Description: May down-regulate host tetherin (BST2) by lysosomal degradation, thereby counteracting its antiviral activity. |
CoV Spike Bovine |
|||
ant-755 | ProSpec Tany | 50µg | EUR 165 |
Description: Mouse Anti Bovine Coronavirus Spike |
CoV Spike Porcine |
|||
ant-756 | ProSpec Tany | 50µg | EUR 165 |
Description: Mouse Anti Porcine Coronavirus Spike |
SARS-CoV-2 (COVID-19) Variant Spike Protein RBD (E484D) Recombinant Protein |
|||
21-829 | ProSci | 0.1 mg | EUR 714.3 |
Description: SARS-CoV-2 (COVID-19) Variant Spike Protein RBD (E484D) Recombinant Protein |
CoV-2 Spike E-Mosaic |
|||
sars-014 | ProSpec Tany | 50µg | EUR 165 |
Description: Recombinant Coronavirus 2019 Spike E-Mosaic |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
|||
10-300 | ProSci | 0.1 mg | EUR 632.4 |
Description: SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
|||
10-107 | ProSci | 0.1 mg | EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
|||
10-109 | ProSci | 0.1 mg | EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
|||
10-111 | ProSci | 0.1 mg | EUR 651.3 |
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction. The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses as well as protective immunity. |
SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |
|||
10-118 | ProSci | 0.1 mg | EUR 651.3 |
Description: SARS-CoV-2 (COVID-19) Spike S1 Recombinant Protein |